Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Disparities in prostate cancer care

Silke Gillessen • 3 Jun 2019
ASCO 2019
Prostate Cancer

Silke Gillessen, MD, of The Christie NHS Foundation Trust, Manchester, UK, discusses the disparities in prostate cancer management and how mortality rates vary worldwide at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

More from Silke Gillessen

2:30
PARP inhibitors plus novel endocrine agents for patients with metastatic prostate cancer
Silke Gillessen • 18 Feb 2023
1:23
The role of immune checkpoint inhibitors in mCRPC
Silke Gillessen • 18 Feb 2023
2:12
Criteria for treatment selection for patients with CRPC
Silke Gillessen • 18 Feb 2023
2:43
Treatment sequencing and combinations for prostate cancer
Silke Gillessen • 18 Feb 2023

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
0:45
SYNC-T combination immunotherapy in mCRPC
George Prendergast • 8 Apr 2024
0:40
PSMA PET findings in 225AC-J591-treated patients with mCRPC
Andres Ricaurte-Fajardo • 9 Apr 2024
0:45
Should radioligand therapies be used in earlier settings in prostate cancer?
Andres Ricaurte-Fajardo • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals